Spyre Therapeutics Inc (SYRE)

Retained Earnings

-$1.23B

Quarterly · Period ending: · USD

SYRE logo

SYRE Retained Earnings

Latest reported-$1.23B
SYRE Quarterly Retained Earnings (-$12.28M → -$1.23B)
High-resolution chart · PNG

SYRE retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-1,232,840,000
-1,196,640,000
-1,127,635,000
-1,065,105,000
-1,053,922,000
-1,017,205,000
-972,432,000
-916,136,000
-847,108,000
-808,271,000
-764,414,000
-701,234,000
-661,127,000
-444,046,000
-425,624,000
-406,802,000
-388,568,000
-366,245,000
-341,809,000
-321,363,000
-301,056,000
-294,226,000
-276,008,000
-253,294,000
-235,261,000
-213,843,000
-195,115,000
-173,620,000
-152,047,000
-134,028,000
-116,861,000
-101,963,000
-90,046,000
-80,632,000
-72,513,000
-66,030,000
-58,156,000
-51,524,000
-45,277,000
-39,794,000
-33,556,000
-28,126,000
-23,579,000
-19,592,000
-16,179,000
-14,752,000
-12,284,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.